Table 4.
Subject | Duration onset and testings (yrs.) |
MMSE /30 |
DRS total /144 |
DRS Attention /37 |
DRS Initiation /Perseveration /37 |
DRS Construction /6 |
DRS Conceptualization /39 |
DRS Memory /25 |
WAIS- Block Design /51 |
COWAT total raw |
AVLT Delayed Recall /15 |
Boston Naming Test /60 |
Total UPDRS /108 |
NPI Total Severity /36 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||
1 | 1.6 | 23 | 109 | 36 | 21 | 6 | 28 | 18 | 23 | 15 | 0 | 8 | NA | NA |
2 | 4 | 22 | 119 | 37 | 31 | 6 | 30 | 15 | 6 | 51 | 0 | 28 | 0 | NA |
3 | 1.8 | 30 | 141 | 35 | 37 | 6 | 39 | 24 | 12 | 45 | 4 | 40 | NA | NA |
4 | 2.1 | 24 | 110 | 37 | 20 | 6 | 36 | 11 | NA | 10 | 0 | 27 | 7 | 2 |
5 | 2.2 | 24 | 118 | 32 | 28 | 6 | 37 | 15 | NA | 28 | 2 | 34 | 0 | 4 |
6 | 0.25 | 22 | 107 | 31 | 26 | 6 | 32 | 12 | 10 | 28 | 0 | 26 | NA | NA |
7 | 2.5 | 28 | 139 | 35 | 37 | 5 | 39 | 23 | 19 | 30 | 5 | 57 | 1 | NA |
8 | 4.3 | 23 | 109 | 33 | 17 | 6 | 35 | 18 | 17 | 0 | 1 | 44 | 8 | 9 |
9 | 1.2 | 29 | 130 | 34 | 37 | 5 | 30 | 24 | NA | 29 | 1 | 55 | 3 | 1 |
10 | 1.4 | 18 | 104 | 33 | 21 | 5 | 33 | 12 | 5 | 24 | 0 | NA | NA | 2 |
11 | 1.7 | 26 | 121 | 36 | 25 | 6 | 37 | 17 | NA | 21 | 5 | 44 | 0 | 0 |
12 | 5.6 | 29 | 134 | 34 | 35 | 6 | 38 | 21 | NA | 22 | 2 | 48 | 5 | 0 |
13 | 4.2 | 18 | 89 | 29 | 18 | 4 | 25 | 13 | NA | 10 | 0 | NA | 0 | 2 |
14 | 1.2 | 13 | 103 | 36 | 20 | 6 | 27 | 14 | 16 | 9 | 1 | 32 | NA | NA |
15 | 5.9 | 20 | 117 | 33 | 30 | 5 | 36 | 13 | NA | 39 | 0 | 59 | 0 | 3 |
MMSE = Mini-Mental State Examination; DRS = Dementia Rating Scale; UPDRS = Unified Parkinson’s Disease Rating Scale; WAIS = Wechsler Adult Intelligence Scale; COWAT = Control Oral Word Association Test; AVLT = Auditory Verbal Learning Test; NPI-Q = brief questionnaire version of the Neuropsychiatric Inventory.